Economist – Go Job Zone

Evolution of orphan drug – Healthcare Economist

December 19, 2024

0 Comments

Evolution of orphan drug – Healthcare Economist

A study by Fermaglich and Miller (2023) evaluated trends in orphan drug designations and approvals after the Orphan Drug ...

Can we measure this? – Healthcare Economist

December 18, 2024

0 Comments

Can we measure this? – Healthcare Economist

A paper by Kowal et al. (2023) does in fact measure the disparities in health outcomes. To do this, they use data from the ...

How many patients are switching to biosimilars? – Healthcare Economist

December 11, 2024

0 Comments

How many patients are switching to biosimilars? – Healthcare Economist

That is a key question if long-run drug prices are going to come down for biologic products. We can ...

Does NICE consider real-world data (RWD) for HTA evaluations? – Healthcare Economist

December 4, 2024

0 Comments

Does NICE consider real-world data (RWD) for HTA evaluations? – Healthcare Economist

The answer is ‘yes’, but the question is in what manner? A paper by Che et al. (2024) examines the use of real-world data ...

Health care in Spain – Healthcare Economist

November 17, 2024

0 Comments

Health care in Spain – Healthcare Economist

ISPOR Europe kicks off this week in Barcelona, Spain. In honor of ISPOR, I will summarize some key attributes ...

Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist

November 4, 2024

0 Comments

Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist

Cost effectiveness analyses (CEA) aim to examine how a new health technologies impact health outcomes and costs over a patient’s lifetime. While extrapolating long-run ...

Merchants of Death – Healthcare Economist

October 31, 2024

0 Comments

Merchants of Death – Healthcare Economist

That is the clever title of recent American Economic Review publication by Cyrus Aghamolla, Pinar Karaca-Mandic, Xuelin Li, Richard ...

Best practices for conducting a scoping review – Healthcare Economist

October 28, 2024

0 Comments

Best practices for conducting a scoping review – Healthcare Economist

Scoping reviews are a type of knowledge synthesis, which follow a systematic approach to map evidence on a topic ...

Use of real-world data for measuring treatment effectiveness for target populations – Healthcare Economist

October 25, 2024

0 Comments

Use of real-world data for measuring treatment effectiveness for target populations – Healthcare Economist

Randomized controlled trials are the gold standard for evaluating treatment efficacy, but effectiveness in the real-world may vary. One reason for this is that ...

‘Employers Haven’t a Clue How Their Drug Benefits Are Managed’ – Healthcare Economist

October 20, 2024

0 Comments

‘Employers Haven’t a Clue How Their Drug Benefits Are Managed’ – Healthcare Economist

That is the title of a KFF article published last week. The results are based on KFF’s 2024 Employer ...

Tag: Economist

Evolution of orphan drug – Healthcare Economist

Can we measure this? – Healthcare Economist

How many patients are switching to biosimilars? – Healthcare Economist

Does NICE consider real-world data (RWD) for HTA evaluations? – Healthcare Economist

Health care in Spain – Healthcare Economist

Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist

Merchants of Death – Healthcare Economist

Best practices for conducting a scoping review – Healthcare Economist

Use of real-world data for measuring treatment effectiveness for target populations – Healthcare Economist

‘Employers Haven’t a Clue How Their Drug Benefits Are Managed’ – Healthcare Economist

Call us

(469) 663-8558

For Candidates

Helpful Resources

About Us

Posts tagged "Economist"

Call us

(469) 663-8558

For Candidates

Helpful Resources

About Us

Ready to find your dream job?​

Ready to find your dream job?​

Ready to find your dream job?

Ready to find your dream job?